Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।
Indications
GLIKAZID MR 30MG Tablet is indicated for:
-
Type 2 Diabetes Mellitus: To control blood glucose levels in patients who are inadequately controlled by diet, exercise, and lifestyle changes.
Pharmacology
Gliclazide is a second-generation sulfonylurea that acts by stimulating pancreatic beta cells to release insulin. The modified-release formulation ensures sustained glycemic control throughout the day, reducing fluctuations in blood sugar levels.
Dosage and Administration
-
Dosage:
-
Start with 30mg once daily. Adjust dose based on glycemic response, up to a maximum of 120mg daily.
-
-
Administration:
-
Take orally with water during breakfast. Do not crush or chew the tablet.
-
Interaction
-
Increased Hypoglycemic Risk: With other antidiabetic drugs, alcohol, beta-blockers.
-
Reduced Efficacy: With corticosteroids, diuretics, or hormonal contraceptives.
Contraindications
-
Hypersensitivity to Gliclazide or other sulfonylureas.
-
Type 1 diabetes or diabetic ketoacidosis.
-
Severe renal or hepatic impairment.
Side Effects
-
Common: Hypoglycemia, dizziness, headache, and nausea.
-
Rare: Allergic skin reactions, gastrointestinal upset, or abnormal liver function tests.
Pregnancy & Lactation
-
Pregnancy: Not recommended. Insulin is preferred for diabetes management during pregnancy.
-
Lactation: Not advised as it may be excreted in breast milk.
Precautions & Warnings
-
Regular monitoring of blood glucose is essential to avoid hypoglycemia.
-
Use cautiously in elderly patients or those with impaired renal or hepatic function.
-
Do not skip meals to minimize the risk of hypoglycemia.
Therapeutic Class
Sulfonylurea (Antidiabetic).
Storage Conditions
-
Store below 30°C in a cool, dry place.
-
Protect from direct light and moisture.
-
Keep out of reach of children.
.jpeg)
 10P.jpg)
.jpg)
 100ML.jpg)
.jpg)
Change Language